3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Triple Negative Breast Neoplasms
2
Breast Neoplasms
2
Prostate Cancer Metastatic
1
Mesothelioma, Malignant
1
Gastrointestinal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
4
tremelimumab
3
Pemetrexed
3
durvalumab
2
atezolizumab
2
Radiotherapy
2
Nivolumab
2
Mitomycin
2
Doxorubicin
2
toripalimab
1
talazoparib
1
rucaparib
1
regorafenib
1
ranpirnase
1
pembrolizumab
1
niraparib
1
liposomal doxorubicin
1
dostarlimab
1
cemiplimab
1
bemcentinib
1
avelumab
1
abemaciclib
1
Vinorelbine
1
Vinblastine
1
Thiostrepton
1
Surgical Procedures, Operative
1
Oxaliplatin
1
One-Lung Ventilation
1
Neoadjuvant Therapy
1
Megestrol Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mesothelioma, Malignant
×
talazoparib
×
Clear all
NCT04462809
2020-07-09
TALAMESO
Hospices Civils de Lyon
Phase 2
Unknown
40 enrolled